Sun Pharma Advanced Research Company Limited — Board Meeting, 04-11-2024: Outcome of Board Meeting

Sun Pharma Advanced Research Company Limited's Board of Directors approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2024, during their recent meeting. The results, along with the Statutory Auditors' Limited Review Report, have been made available on the company’s website.